Mayne Pharma Group Limited (ASX:MYX)
Mayne Pharma Group Limited (ASX:MYX) is a pharmaceutical company focused on applying its drug delivery expertise to commercialise branded and generic pharmaceuticals.
Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.
Mayne Pharma has a track record of innovation and success in developing new oral drug delivery systems and these technologies have been successfully commercialised in many products marketed around the world.
Mayne Pharma has two facilities based in Salisbury, Australia and Greenville, USA with expertise in the formulation of complex oral and topical dose forms including potent compounds, modified-release products and poorly soluble compounds.